(Date:11/23/2009)...,, LANSING,Mich.,Nov.23/PRNewswire-FirstCall...hatRichardT.Crowder,Ph.D.,waselectedtoNeogen,sBoar...reholders. ,, Crowderhasmorethan40yearsofexperi...rentlyservesasanadjunctprofessorofagriculturalecon...May2007,heservedasUnitedStateschiefagriculturenego...
(Date:11/23/2009)...,, REDWOODCITY,Calif.,Nov.23/PRNewswire/--Pe...opingtherapeuticproductsforthetreatmentofchronicre...wieRosentothecompany,sBoardofDirectors.Mr.Rosenhas...logyindustries,includingkeyrolesatGileadSciencesan...fdirectorsonPearl,sBoardtosix. ,, "Howiebringsa...
(Date:11/20/2009)..., , SEATTLE, Nov. 20 /PRNewswire-FirstCal...announced that the U.S. Food and Drug Administrati... Company,s amended Biologics License Application (...te response. The FDA has assigned a Prescription ...which time it will respond to Dendreon,s amended B...
(Date:11/20/2009)..., METTLER TOLEDO recently...t a free webinar, “The Role of Process Analy...n Engineering” on December 1, 2009. , ...ring the The Role of Process Analytical Technolog...ebinar on December 1, Process Analytical Technolo...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2...itute,(RSCI) today announced two additions to its ...ing its stem cell research proficiency in the proc...first five appointees had two,things in common: pi...ng,patients with a variety of illnesses considered...hers, David Matzilevich, M.D., Ph.D. and Mariano,U...
...erapeutics,company, today announced the completion...One Capital and new investor Aravis Venture.,Addit...h Fund advised by,Adamant Biomedical Investments A...ze the proceeds to primarily fund the development ...nhibitor, and SB1518, a JAK 2 inhibitor,both in Ph...
...RNewswire-FirstCall/ - Resverlogix Corp.,("Resverl...Stock Exchange,has approved Resverlogix,s previous...deeming of US $10 million of its remaining US $17....debenture including accrued,interest earned to Oct...reholders with understanding the salient and benef...
Other Biology Technology:RSCI Announces Two Additions to Its Science Advisory Board, Calling for More Stem Cell Research on Diabetes 2S*BIO Completes US$26 Million Equity Financing 2S*BIO Completes US$26 Million Equity Financing 3S*BIO Completes US$26 Million Equity Financing 4(Date:11/23/2009)...rch presents strong evidence that the "synergistic...affic-related pollution and indoor endotoxin cause...her exposure alone. , Environmental health sci...ge of Medicine have shown that children exposed to... indoor endotoxin during early life are six times ...
(Date:11/23/2009)...ore than 160 participants gathered this week for t...INITIATIVE conference. This year,s topic, "Synthet...s, and medical researchers to explore the engineer... emerging field of synthetic biology. , Bonnie L...eton University and this year,s conference chair, ...
(Date:11/23/2009)...er 16, 2009 -- A USDOE and USDA study concluded th...d, and cropland pasture could be converted from cu... such as switchgrass, from which biomass could be ...ally viable production of a perennial grass monocu... are removed annually is expected to require nitro...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Switchgrass produces biomass efficiently 2IBM Analytics Expands To Help Governments Around World Build Smarter Systems 54203 1IBM Analytics Expands To Help Governments Around World Build Smarter Systems 54203 2IBM Analytics Expands To Help Governments Around World Build Smarter Systems 54203 3IBM Analytics Expands To Help Governments Around World Build Smarter Systems 54203 4Grifols Honors Texas Plasma Donors During Plasma Protein Therapies Month 54201 1Grifols Honors Texas Plasma Donors During Plasma Protein Therapies Month 54201 2Video 3A Provectus Pharmaceuticals Updates Shareholders On 2009 Year To Date Accomplishments 54199 1Video 3A Provectus Pharmaceuticals Updates Shareholders On 2009 Year To Date Accomplishments 54199 2Video 3A Provectus Pharmaceuticals Updates Shareholders On 2009 Year To Date Accomplishments 54199 3Video 3A Provectus Pharmaceuticals Updates Shareholders On 2009 Year To Date Accomplishments 54199 4Video 3A Provectus Pharmaceuticals Updates Shareholders On 2009 Year To Date Accomplishments 54199 5Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Anti-Mouse Laminin-1 Monoclonal Antibody, Unconjugated, Clone AL-3 from R&D Systems
Rabbit Anti-Rat Potassium Channel EAG-1 Antibody, Unconjugated from CHEMICON
Goat Anti-IEX-1 S / L Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: